Engineers pH-responsive nanocarriers to deliver potent therapeutic proteins exclusively into targeted tumor zones.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Red Arrow Therapeutics develops novel cancer therapies by transforming proinflammatory biology into innovative treatments using nanopolymer drug delivery technology. The company’s lead asset focuses on pioneering Interleukin-12 prodrug technology to create safe and effective solutions for cancer patients worldwide.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Red Arrow Therapeutics Management Team
Investors
Beyond Next Ventures
Keio Innovation Initiative
OSAKA University Venture Capital
The University of Tokyo Edge Capital Partners
Red Arrow Therapeutics Valuations & Financials
View real-time NPM data on Red Arrow Therapeutics stock including daily Red Arrow Therapeutics stock price estimates, valuation history, and historical share price information. Access Red Arrow Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Red Arrow Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Red Arrow Therapeutics? Get in touch to learn more.
Similar Companies
like Red Arrow Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
InSoma
Healthcare & Life Sciences
Develops injectable, body-activated biomaterials that support natural tissue integration for safer, more effective reconstructive surgeries.
Lemonilo
A health-focused brand that provides natural food products, aiming to foster a community committed to healthy living.
Enlaza Therapeutics
Healthcare & Life Sciences
Engineering that locks protein therapeutics onto disease targets for lasting effect with minimized systemic exposure.
Prompt AI
Empowers users to convert visual data into searchable databases and build shareable computer vision solutions.
Quantive
Enterprise Software
Provides an AI-driven platform that helps organizations plan, execute, and adapt strategies by integrating data and automating insights.
RLTYco
Provides real estate professionals with financial, legal, tax, and healthcare services to simplify and support their business operations.
Unlocked Reality
Media & Entertainment
Delivering untethered, natural VR movement via smart friction-control platforms for immersive, intuitive locomotion.
Culture Amp
A leading employee experience platform that utilizes data-driven insights to improve engagement, performance, and development within organizations.
FAQ
We have answers
Red Arrow Therapeutics stock does not trade on public stock exchanges. Red Arrow Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Red Arrow Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Red Arrow Therapeutics Stock does not trade on public stock exchanges. In order to sell Red Arrow Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Red Arrow Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Red Arrow Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Red Arrow Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Red Arrow Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Red Arrow Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Red Arrow Therapeutics is a private company and has not had an IPO. There is currently no Red Arrow Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Red Arrow Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
